Catalyst Wire Dossier Catalyst Wire Dossier

Vero Cell inactivated SARS-CoV-2 vaccine (Omicron variant booster)

SARS-CoV-2 inactivated vaccine · Sinovac Research and Development Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vero Cell inactivated SARS-CoV-2 vaccine (Omicron variant booster), covering 2024-05-31 to 2024-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above [Phase 3]

See pricing